ROZEREM ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
6Parkinson disease1

6. Parkinson disease


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00462254
(ClinicalTrials.gov)
June 200716/4/2007Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's DiseaseRamelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's DiseaseParkinson's DiseaseDrug: ROZEREM;Drug: RamelteonSouthern California Institute for Research and EducationNULLTerminated45 Years85 YearsBoth4Phase 4United States